Status:
UNKNOWN
Evaluation of Stress Sensitivity and Hyperemotivity in Epilepsy Compared to and a Group of Healthy Volunteers
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Epilepsy
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Recently, a possible subtype of temporal lobe epilepsy (TLE) has been proposed: this subtype presents ipsilateral amygdala enlargement (AE) without any other lesion. However, little is known about its...
Detailed Description
TLE-AE could concern 16 to 64 % of the TLE with "negative" MRI (Beh et al., 2016). TLE-AE patients may suffer from anxiety and depression (Lv et al, 2014). In clinical practice, it has been also iden...
Eligibility Criteria
Inclusion
- \- For all epileptic patients: Age between 18 and 65. Epilepsy (TLE or not) followed by an epileptologist.
- \- For TLE-AE: An AE identified on the MRI by an expert neuroradiologist. MRI must be less than one year.
- \- For non AE epileptic patients: No AE reported in the MRI by an expert neuroradiologist.
Exclusion
- Any mental disorder.
- Any diabetes
- Beta-blockers
- Neuroleptics
- Any neurologic diseases for the healthy volunteers.
Key Trial Info
Start Date :
March 8 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2020
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03464370
Start Date
March 8 2018
End Date
March 1 2020
Last Update
July 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Toulouse
Toulouse, France, 31059